Exosomes derived from human adipose tissue-derived mesenchymal stem cells for the treatment of dupilumab-related facial redness in patients with atopic dermatitis: A report of two cases.
Kui Young ParkHye Sung HanJae Wan ParkHyuck Hoon KwonGyeong-Hun ParkSeong Jun SeoPublished in: Journal of cosmetic dermatology (2021)
We suggest that human adipose tissue-derived mesenchymal stem cell-derived exosomes may serve as an effective agent in the management of dupilumab facial redness. However, further controlled studies with a larger number of patients are necessary to confirm the efficacy and safety of this agent, as well as the optimal treatment protocol.
Keyphrases
- atopic dermatitis
- adipose tissue
- endothelial cells
- stem cells
- end stage renal disease
- mesenchymal stem cells
- insulin resistance
- high fat diet
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- induced pluripotent stem cells
- newly diagnosed
- prognostic factors
- bone marrow
- type diabetes
- pluripotent stem cells
- metabolic syndrome
- skeletal muscle
- patient reported
- case control